Skip to main content
Log in

NICE draft guidance on alirocumab: not recommended

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. low density lipoprotein cholesterol

  2. National Health Service

Reference

  • NICE. NICE issues draft guidance on alirocumab for lipid disorder. Media Release : 8 Feb 2016. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE draft guidance on alirocumab: not recommended. PharmacoEcon Outcomes News 746, 32 (2016). https://doi.org/10.1007/s40274-016-2810-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2810-1

Navigation